Ottawa Health Research Institute
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
9
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (55.6%)Phase 2
3 (33.3%)Phase 1
1 (11.1%)Self-Guided Immersive Virtual Reality Versus Mannequin-based Simulators to Teach the Ultrasound-Guided Supra-Inguinal Fascia Iliaca Block
Not Applicable
Recruiting
- Conditions
- Nerve BlockHip Fracture Surgeries
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT07035015
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform
Not Applicable
Completed
- Conditions
- Mobile AppsImmunizationAdverse Event Following Immunisation
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 2408
- Registration Number
- NCT05794113
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Standardization of Post-operative Opiate Prescriptions for Same-day Ankle and Wrist Fracture Surgeries
Not Applicable
- Conditions
- Prescription Opioid AbuseSurgeryOpioid UseFracture WristPost-operative PainFracture, Ankle
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05322564
Minimal Invasive Surgical Intracerebral Hemorrhage Removal
Not Applicable
Not yet recruiting
- Conditions
- Intracranial Hemorrhages
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT05138341
Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study
Not Applicable
Withdrawn
- Conditions
- Breast CancerAxillary Lymphadenitis
- First Posted Date
- 2019-10-23
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- The Ottawa Hospital
- Registration Number
- NCT04136496
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
- Prev
- 1
- 2
- Next
News
Canadian-Developed CAR T-Cell Therapy Targeting CD22 Heads to Clinical Trials
The National Research Council of Canada has developed a novel CAR T-cell therapy targeting the CD22 protein on B-cell leukemia and lymphoma cells, offering hope for patients who failed previous CD19-targeted treatments.